Valuation: Strides Pharma Science Limited

Market Cap 98.99B 1.03B 907M 840M 773M 1.46B 1.49B 10.01B 3.93B 48.61B 3.88B 3.8B 168B P/E 2026
15.5x
P/E 2027 * 15.8x
Enterprise Value 98.99B 1.03B 907M 840M 773M 1.46B 1.49B 10.01B 3.93B 48.61B 3.88B 3.8B 168B EV / Sales 2026
1.78x
EV / Sales 2027 * 1.7x
Free-Float
68.07%
Yield 2026
0.53%
Yield 2027 * 0.28%
1 day-0.28%
1 week-5.07%
Current month-2.00%
1 month-1.32%
3 months+6.92%
6 months+13.94%
Current year+18.95%
1 week 1,052
Extreme 1052
1,127.8
1 month 1,052
Extreme 1052
1,149.8
Current year 768.65
Extreme 768.65
1,231
1 year 768.65
Extreme 768.65
1,231
3 years 412.1
Extreme 412.1
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 2024-05-31
Director of Finance/CFO 42 2024-05-31
Chief Tech/Sci/R&D Officer - 2024-11-20
Director TitleAgeSince
Chairman 65 -
Director/Board Member 82 2017-05-17
Director/Board Member 64 2024-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-5.07%+17.69%+145.75% 1.03B
+1.14%+2.09%+15.49%+81.11% 48.17B
+0.36%-4.47%+66.16%+115.81% 35.47B
+1.02%-0.62%-2.78%+39.96% 12.04B
+0.51%-1.39%+17.40%+90.98% 11.79B
+0.19%+1.53%+33.50%+127.47% 9.15B
+0.59%-2.52%+17.93%+36.80% 6.91B
+1.33%-1.06%+48.46%-4.10% 6.95B
-0.08%+1.56%+3.65%+227.63% 6.79B
-5.52%-11.93%-22.06%+7.41% 5.77B
Average -0.06%-2.74%+19.55%+86.88% 14.41B
Weighted average by Cap. +0.48%-2.31%+27.40%+88.15%

Financials

2026 2027 *
Net sales 48.28B 504M 442M 410M 377M 713M 727M 4.88B 1.92B 23.71B 1.89B 1.85B 81.88B 58.23B 608M 534M 494M 455M 860M 877M 5.89B 2.31B 28.6B 2.28B 2.23B 98.75B
Net income 5.74B 59.94M 52.57M 48.69M 44.8M 84.74M 86.39M 580M 228M 2.82B 225M 220M 9.73B 6.28B 65.59M 57.52M 53.28M 49.02M 92.72M 94.53M 635M 249M 3.08B 246M 241M 10.65B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,301
Date Price Change Volume
26-07-14 1,071.80 -0.20% 42,684
26-07-13 ₹1,074.00 -0.79% 97,494
26-07-10 ₹1,082.60 +0.61% 301,869
26-07-09 ₹1,076.00 -0.44% 217,028
26-07-08 ₹1,080.80 -4.20% 109,464
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,074.00INR
Average target price
1,338.67INR
Spread / Average Target
+24.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock